Ceva Launches New Gabbrovet Multi To Treat Scour In Calves Caused By Cryptosporidiosis And E.Coli

2 years ago
1734 views

Posted
3rd September, 2023 09h25

Author
Ceva

Ceva Animal Health has launched NEW Gabbrovet Multi, which is now the first and only ready to use solution licensed to treat both cryptosporidium and E.Coli diarrhoea in calves¹.

Cryptosporidiosis is the most common cause of neonatal diarrhoea in calves under one month of age², while E.Coli is considered the second most important pathogen affecting calves on UK farms³.  Neonatal diarrhoea not only contributes to increased mortality, reduced growth rate^{4, 5}, delayed age at first calving and decreased milk production⁶, but contact with infected livestock has been found to be the source of human cryptosporidium in up to 38% of cases⁷.

Gabbrovet Multi contains paramomycin as its active ingredient and replaces Gabbrovet^® Solution.  In a study⁸of 334 calves with severe diarrhoea, those receiving Gabbrovet Multi showed a faster and more effective response than those given halofuginone.

“Gabbrovet Multi is the first and only ready to use solution for the convenient treatment of both cryptosporidium and E.Coli, two of the most common causes of neonatal scour in calves,” comments Harry Walby, ruminant veterinary advisor at Ceva Animal Health. “Alongside Gabbrovet Multi, Ceva also has a wide range of products to support the management of calves with scour including Meloxidyl^®, Rehydion^® and Diarsanyl^®.”

Gabbrovet Multi can be administered in milk or water.  The ready to use solution is available with a dosing cap and it comes in 250ml, 500ml or 1l presentations.

For further information on Gabbrovet Multi, which also treats gastro-intestinal infections caused by E.Coli in pigs, contact your local Ceva Animal Health territory manager or email [email protected].

References

1. Gabbrovet Multi and other product SPCs - https://www.vmd.defra.gov.uk/productinformationdatabase/
2. Thomson, S., Hamilton, C.A., Hope, J.C. et al. Bovine cryptosporidiosis: impact, host-parasite interaction and control strategies. Vet Res 48, 42 (2017). https://doi.org/10.1186/s13567-017-0447-0
3. FMR Global Health / survey conducted in FR, GER, UK, BE, DK, PL and SP in March 2022
4. Pardon, B., Hostens, M., Duchateau, L. et al. Impact of respiratory disease, diarrhoea, otitis and arthritis on mortality and carcass traits in white veal calves. BMC Vet Res 9, 79 (2013). https://doi.org/10.1186/1746-6148-9-79
5. Windeyer MC, Leslie KE, Godden SM, Hodgins DC, Lissemore KD, LeBlanc SJ. Factors associated with morbidity, mortality, and growth of dairy heifer calves up to 3 months of age. Prev Vet Med. 2014 Feb 1;113(2):231-40. doi: 10.1016/j.prevetmed.2013.10.019
6. Svensson C, Hultgren J. Associations between housing, management, and morbidity during rearing and subsequent first-lactation milk production of dairy cows in southwest Sweden. J Dairy Sci. 2008 Apr;91(4):1510-8. doi: 10.3168/jds.2007-0235
7. Chalmers RM, Robinson G, Elwin K, Elson R. Analysis of the Cryptosporidium spp. and gp60 subtypes linked to human outbreaks of cryptosporidiosis in England and Wales, 2009 to 2017. Parasit Vectors. 2019 Mar 12;12(1):95. doi: 10.1186/s13071-019-3354-6
8. Damien Achard, Béatrice Besche-Barbazanges , Gaëlle Pagny, Jean-François Collin, Dejan Cvejić. Efficacy of an oral solution of paromomycin for the treatment of newborn dairy calves with cryptosporidiosis - Results from a comparative European multicentric field study, Presented at the 31^st World Buiatrics Congress 2022

More from Ceva

• Ease Pet Anxiety This Fireworks Season with Ceva's Vet-Approved Solutions
• Ceva and International Cat Care launch season 2 of cat handling training videos
• Ceva launches service to highlight the cost of infertility linked to Q fever
• Are vets and farmers under-using pain relief in dairy cows?
• Ceva hosts ‘Break the Pain’ dairy cow conference